Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• D. Boral Capital analyst Jason Kolbert downgraded Quince Therapeutics Inc (NASDAQ:QNCX) from Buy to Hold. Quince Therapeutics shares closed at $0.2701 on Thursday. See how other analysts view this stock.
• Stifel analyst Jeffrey Stantial downgraded Codere Online Luxembourg, S.A. (NASDAQ:CDRO) from Buy to Hold and cut the price target from $9 to $8.5. Codere Online Luxembourg shares closed at $7.91 on Thursday. See how other analysts view this stock.
• Citizens analyst Jonathan Wolleben downgraded the rating for Quince Therapeutics, Inc. (NASDAQ:QNCX) from Market Outperform to Market Perform. Quince Therapeutics shares closed at $0.2701 on Thursday. See how other analysts view this stock.

Considering buying CDRO stock? Here’s what analysts think:

Photo via Shutterstock

• No comments yet. Be the first to comment!